FY2028 EPS Estimate for C4 Therapeutics Reduced by Analyst
C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) – Stock analysts at Brookline Capital Management cut their FY2028 EPS estimates for C4 Therapeutics in a research note issued to investors on Wednesday, May 7th. Brookline Capital Management analyst L. Cann now forecasts that the company will earn $1.95 per share for the year, down from their […]
C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) – Stock analysts at Brookline Capital Management cut their FY2028 EPS estimates for C4 Therapeutics in a research note issued to investors on Wednesday, May 7th. Brookline Capital Management analyst L. Cann now forecasts that the company will earn $1.95 per share for the year, down from their […]
